Aktas, A. Et Al. 2022. The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.. Annals of Medical Research , vol.29, no.8 , 846-852.

Aktas, A., Gunes, O., Budak, F., Diller, N., Tuncer, A., Akbulut, S., ... Taskapan, M.(2022). The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.. Annals of Medical Research , vol.29, no.8, 846-852.

Aktas, Ayd Et Al. "The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.," Annals of Medical Research , vol.29, no.8, 846-852, 2022

Aktas, Ayd Et Al. "The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.." Annals of Medical Research , vol.29, no.8, pp.846-852, 2022

Aktas, A. Et Al. (2022) . "The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.." Annals of Medical Research , vol.29, no.8, pp.846-852.

@article{article, author={Ayd Aktas Et Al. }, title={The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure.}, journal={Annals of Medical Research}, year=2022, pages={846-852} }